{"schema_version":"secwatch.filing_event.v1","accession":"0001552781-24-000494","form_type":"8-K","ticker":"SWKHL","cik":"0001089907","company_name":"SWK Holdings Corp","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.141490+00:00","generated_at":"2026-05-31T08:56:51.260357+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"SWK Holdings Q2 2024 revenue up 21% to $11.5M; GAAP net income $4.4M vs $3.9M YoY","bullets":["Finance receivables segment revenue rose 15.3% to $10.7M; adjusted non-GAAP net income fell to $6.5M from $7.6M YoY.","Provision for credit losses totaled $4.1M driven by impairments on Trio ($2.1M) and Exeevo ($2.2M) loans.","Non-accrual finance receivables were $22.4M at June 30, 2024; portfolio includes Flowonix, Exeevo, Ideal Implant, Best ABT, Trio.","Post-quarter closed up to $11M royalty financing with Relief Therapeutics; $5.8M advanced at close.","Non-GAAP tangible financing book value per share grew 6.4% to $20.17; GAAP book value per share $22.75."],"urls":{"canonical":"https://secwatch.observer/filing/0001552781-24-000494","json":"https://secwatch.observer/filing/0001552781-24-000494.json","markdown":"https://secwatch.observer/filing/0001552781-24-000494.md","text":"https://secwatch.observer/filing/0001552781-24-000494.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1089907/000155278124000494/0001552781-24-000494-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1089907/000155278124000494/e24351_swkh-8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:56:51.260357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}